SGLT2 Inhibitors: The Good, the Bad, and the Ugly

Dr. Centor discusses the risks and benefits of using SGLT2 inhibitors to treat patients with type 2 diabetes with Dr. Katherine Tuttle, an endocrinologist and nephrologist at Washington State University.

Episode metadata supplied by the publisher feed · Published Aug 5, 2019

Embed this episode

Attribution link and audio player

NOW PLAYING

SGLT2 Inhibitors: The Good, the Bad, and the Ugly

0:00 34:50

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Annals On Call Podcast?

This episode is 34 minutes long.

When was this Annals On Call Podcast episode published?

This episode was published on August 5, 2019.

Can I download this Annals On Call Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!